Merck to streamline business, separate into two companies

Merck& Co. Inc. unveiled plans Wednesday to spin off products from its women ’s health and biosimilars businesses, along with certain legacy brands, into a new independent and publicly traded company. Going forward, Merck (NYSE: MRK) will focus on its oncology, vaccines, hospital medicine and animal health segments. "Over the past several years, we have purposefully shi fted the focus of our efforts and resources to our best opportunities for growth," said Merck Chairman and CEO Kenneth C. Frazier,…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Source Type: news